Tricuspid stenosis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | |||
{{CMG}} {{AE}} [[User:Mohammed Salih|Mohammed Salih, M.D.]] {{sali}} | |||
==Overview== | ==Overview== | ||
Latest revision as of 21:45, 1 April 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[2]
Overview
Effective measures for the primary prevention of tricuspid stenosis include no intravenous drug use and careful dental hygiene.
Primary Prevention
- In cases of tricuspid stenosis with past medical history of intravenous drug use or bacterial endocarditis as the precipitating event, emphasize careful dental hygiene.
- Maximize drug detoxification efforts with routine antibiotic coverage should be administered for prevention of endocarditis.